-
AstraZeneca Pharmaceuticals LP et al v. Cobalt Pharmaceuticals Inc. et al DC CAFC
- 1:07-cv-00811
- D. Del.
- Judge: Joseph J. Farnan, Jr
- Filed: 12/11/2007
- Closed: 07/13/2010
- Latest Docket Entry: 10/09/2013
- PACER
- Docket updated daily
4
Plaintiffs
2
Defendants
1
Accused
Product
1
Patent-in-Suit
946
Days in
Litigation
-
AstraZeneca Pharmaceuticals LP et al v. Cobalt Pharmaceuticals Inc. et al DC CAFC
- 1:07-cv-00811
- D. Del.
- Judge: Joseph J. Farnan, Jr
- Filed: 12/11/2007
- Closed: 07/13/2010
- Latest Docket Entry: 10/09/2013
- PACER
- Docket updated daily
Cause of Action
Infringement
Market Sector
Biotech and Pharma
Court
Assigned Judge
Outcome Summary
- Patent Information
-
Validity & Enforceability
| Claim # | Claim Text | Outcome |
|---|---|---|
| 6 |
<INS-S DATE="20010807" ID="INS-S-00002">6. The compound
view more
|
Enforceable and Valid
Entry 262 |
| 8 |
<INS-S DATE="20010807" ID="INS-S-00004">8. The compound of claim <HIL><BOLD>6</BOLD></HIL> in the form of a calcium salt.<INS-E ID="INS-S-00004">
|
Enforceable and Valid
Entry 262 |
-
Infringement
Cobalt Laboratories Incorporated
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Generic Crestor | US RE37,314 E1 |
6, 8
|
Infringement
Entry 262Entry 260 |
Cobalt Pharmaceutiacls Incorporated
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Generic Crestor | US RE37,314 E1 |
6, 8
|
Infringement
Entry 262Entry 260 |
